Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 43.43 Delayed Data As of Jan 27 |  0.00 / 0.00%Today’s Change | 18.47 Today|||52-Week Range 46.90 | +14.32% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Ryder Steven W Director |  Gift | 7/11/2022 | 4,171 | $32.36 | $135.0K | +34.09% |
Ryder Steven W Director | Gift | 7/11/2022 | 3,794 | $32.36 | $122.8K | +34.09% |
Ryder Steven W Director | Gift | 7/11/2022 | 913 | $32.36 | $29.5K | +34.09% |
Anand Bhaskar Chief Accounting Officer & Vice President | Gift | 1/03/2023 | 8,250 | $0.00 | $0.00 | +18.20% |
Bir Dawn Carter Chief Commercial Officer | Gift | 1/03/2023 | 15,675 | $0.00 | $0.00 | +18.20% |
Khan Samina /quark/ Chief Medical Officer & Senior Vice President | Gift | 1/03/2023 | 11,756 | $0.00 | $0.00 | +18.20% |
Loewen Rodriguez Andrea | Gift | 1/03/2023 | 11,756 | $0.00 | $0.00 | +18.20% |
Meyer Colin Chief Innovation Officer | Gift | 1/03/2023 | 23,513 | $0.00 | $0.00 | +18.20% |
Wortley Michael D Chief Legal Officer | Gift | 1/03/2023 | 15,675 | $0.00 | $0.00 | +18.20% |
Soni Manmeet Singh | Gift | 1/03/2023 | 23,513 | $0.00 | $0.00 | +18.20% |
Page of 2